Back

Mendelian randomisation for heart failure drug target validation.

29 June 2021 (08:25 - 08:37)
Organised by:
Congress Presentation Part of: Genomics and heart failure: are we ready for prime time? Big Data Analysis HFA Premium Access Heart Failure 2021

About the speaker

Photo
Doctor Benoit Tyl

La Garenne Colombes Cedex (France)

2 More presentations in this session

Presentation thumbnail
Usefulness of polygenic scores in precision medicine.
Professor H. Schunkert (Munich, DE)
Slides Video
Presentation thumbnail
Genome-wide association analysis to better understand heart failure pathogenesis.
Professor T. Lumbers (London, GB)
Slides Video

Access the full session

Session thumbnail
Genomics and heart failure: are we ready for prime time?
Video

The Event

Event poster

Heart Failure 2021

29 June 2021 08:25 CET
You may be interested in
thumbnail
Congress Presentation
A proteo-genomic discovery approach to identify markers of early heart failure
1 September 2025
thumbnail
Congress Presentation
Sex-specific drug-target Mendelian randomisation on the effects of lipid-modifying targets on cardiovascular disease
4 April 2025
thumbnail
Congress Presentation
New medical therapy beyond conventional neuro-hormonal blockade in heart failure with reduced ejection fraction: a systematic review and network meta-analysis
29 June 2021
thumbnail
ESC TV Today
Episode 26: Lp(a): the future starts now - Myocardial infarction in older age and frailty
6 November 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources